Philips Medical Systems Recalls Operating Room Table Over Hazard
Philips Medical Systems Netherlands B.V. recalled three Allura Xper FD20/20 OR Tables on September 3, 2025. The recall addresses potential failures in internal components that could impede motorized functions. Users must stop using the device immediately and follow recall instructions.
Hazard Information
Systems may not perform as intended due to the deterioration of certain internal components (the CMOS battery, hard disk drive, and/or power supply unit). If this deterioration occurs, motorized movements of the system will become unavailable. Manual movements of the stand (longitudinal, transversal and rotational for ceiling mounted systems and rotational for floor mounted systems) and table longitudinal movements remain available. Imaging (X-ray) functionality remains available.
What You Should Do
Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact PHILIPS MEDICAL SYSTEMS NEDERLAND B.V. or your healthcare provider for instructions. Notification method: Letter
Product Details
The recalled product is the Allura Xper FD20/20 OR Table, Product Code 722039. It has associated 510(k) numbers K102005, K130842, K130638, K133292, K141979, K161563, K162859, K033737, and K041949. The product was distributed worldwide.
The Hazard
The operating room table may fail due to deterioration of internal components like the CMOS battery, hard disk drive, or power supply unit. If this occurs, motorized movements become unavailable, potentially impacting patient safety.
Reported Incidents
There are no reported injuries or incidents related to this recall. The manufacturer advises immediate cessation of use to prevent any potential risks.
What to Do
Stop using the operating room table immediately. Follow the recall instructions provided by Philips Medical Systems. Contact your healthcare provider or Philips for further instructions.
Contact Information
For more information, contact Philips Medical Systems Netherlands B.V. through their official website or customer service.
Glenmark Pharmaceuticals Inc. recalled 13,824 tubes of Azelaic Acid Gel on September 17, 2025. The recall stems from market complaints regarding a gritty texture. Consumers should stop using the product immediately and contact their healthcare provider.
Skin MD by Dr Monika Kiripolsky recalled its Body Acne Cleanser on September 12, 2025. The recall follows the discovery of elevated benzene levels in the product. This contamination poses a high health risk to consumers in California and Georgia.
Private Label Skin Care recalled its Micronized BPO Gel Cleanser 10% on September 12, 2025. Elevated benzene levels prompted the recall in California and Georgia. Consumers must stop using the product immediately and seek guidance from healthcare providers.